News

TheraBiogen said that the order represents both the TheraMax Cold & Flu relief spray and the TheraMax Allergy relief spray. TheraBiogen is a manufacturer and distributor of homeopathic

The exchange follows recent milestones achieved by Calando, including several notable first accomplishments in RNAi technology that include proof of the first definitive systemic siRNA delivery and first

Dynavax Phase 1b study is expected to evaluate the safety of the combination of N8295 and Novartis’ investigational H5N1 avian influenza vaccine. N8295 is a fusion protein comprised

As a vice president of Corporate Development, Xing Shen will oversee the company’s strategic business development and internal investor relations functions. Prior to his tenure with Lotus Pharma,

Most recently, Cohen worked as the chief scientific officer in Rosetta Genomics, a developer of microRNA-based molecular diagnostics. Asterand CEO Martyn Coombs said that Cohen has a reputation

As per the extended agreement, Pfizer is expected to continue to fund all aspects of the collaboration including research efforts at both companies and all clinical development costs

As per the terms of the agreement, Lonza is expected to market Scarab Genomics’Clean Genome technology, giving Lonza customers full access to the platform for protein and plasmid

Medtronic said that the findings include one-year results for Resolute International, two subsets from Resolute All Comers, and four-year results for the Resolute feasibility study, which supported the

Bardoxolone methyl, which is currently in late Phase 2 trials, is an oral, antioxidant inflammation modulator that works by increasing the estimated glomerular filtration rate (eGFR) of the